Alnylam Pharmaceuticals, INC. (ALNY) SEC Filings — 2024
20 SEC filings for Alnylam Pharmaceuticals, INC. (ALNY) in 2024.
Filings
- Alnylam Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Alnylam Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Nov 8, 2024
- Alnylam Pharmaceuticals Q3 2024 Update — 10-Q · Oct 31, 2024
- Alnylam Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Aug 12, 2024
- Alnylam Pharmaceuticals Q2 2024 10-Q Filing — 10-Q · Aug 1, 2024
- Alnylam Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Jul 5, 2024
- Alnylam Pharmaceuticals Files 8-K on Shareholder Votes — 8-K · May 20, 2024
- Alnylam Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 2, 2024
- Alnylam Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · Apr 1, 2024
- Alnylam Pharmaceuticals Appoints New CMO and Director — 8-K · Mar 4, 2024
- Alnylam Pharmaceuticals, Inc. Files 2023 Annual Report (10-K) — 10-K · Feb 15, 2024
- Alnylam Files 8-K on Financial Results and Operations — 8-K · Feb 15, 2024
- Alnylam Pharmaceuticals, INC. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Capital World Investors Cuts ALNY Stake to 13.5% — SC 13G/A · Feb 9, 2024
- FMR LLC & Abigail Johnson Disclose 8.239% Stake in Alnylam Pharma — SC 13G/A · Feb 9, 2024
- Wellington Management Amends Alnylam Pharma Stake (12th Update) — SC 13G/A · Feb 9, 2024
- Baillie Gifford Updates Alnylam Pharma Stake (SC 13G/A) — SC 13G/A · Jan 29, 2024
- BlackRock Amends ALNYLAM PHARMACEUTICALS Stake (SC 13G/A) — SC 13G/A · Jan 26, 2024
- Alnylam 8-K: Officer Compensation, Director Changes Reported — 8-K · Jan 19, 2024
- Alnylam 8-K Signals Upcoming Financial Disclosure — 8-K · Jan 8, 2024